封面
市場調查報告書
商品編碼
1402077

全球醫用吸入一氧化氮市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Medical Inhaled Nitric Oxide Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

全球醫用吸入一氧化氮市場需求預計將從 2022 年的 985.56 百萬美元達到 2030 年近 1892.87 百萬美元的市場規模,2023-2030 年研究期間CAGR為 8.5%。

醫用吸入一氧化氮 (iNO) 是一種氣體藥物,用於治療各種呼吸系統疾病,特別是那些涉及肺動脈高壓或低氧血症(低血氧水平)的疾病。它透過吸入作為一種治療干預措施來改善氧合和控制肺血管疾病。

市場動態

急性呼吸窘迫症候群 (ARDS) 和肺動脈高壓等呼吸系統疾病的發生率不斷增加,推動了對吸入一氧化氮 (iNO) 等治療方法的需求,以控制這些疾病並增強氧合。在新生兒護理中,iNO 在治療新生兒持續性肺動脈高壓方面發揮關鍵作用,這與對早產兒健康的高度關注和新生兒護理實踐的進步相一致。醫療保健技術的進步、改進的輸送系統和監測工具提高了 iNO 療法的安全性和有效性,擴大了其在臨床環境中的採用。 iNO 在治療肺血管疾病和改善氧合方面的臨床有效性已得到證實,這促進了其在醫療保健專業人員中的接受度。此外,正在進行的研究探索 iNO 在治療其他呼吸系統疾病方面的潛力,加上監管支持和醫療保健支出的增加,共同推動了市場擴張。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球醫用吸入一氧化氮市場的各個細分市場進行了包容性評估。醫用吸入一氧化氮產業的成長和趨勢為本研究提供了整體方法。

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲醫用吸入一氧化氮市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。醫用吸入一氧化氮市場的主要參與者包括 Bellerophon Therapeutics、Praxair Technology Inc.(Linde plc)、Mallinckrodt Pharmaceuticals、GE Healthcare、Mitsubishi Tanabe Pharma Corporation、Vero Biotech LLC、Messer Group、Air Liquide、Nu-Med Plus、Beyond航空公司等。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:醫用吸入一氧化氮 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析:按產品類型
    • 按給藥途徑進行的市場吸引力分析
    • 市場吸引力分析:依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球醫用吸入一氧化氮市場分析:依產品類型

  • 概述:按產品類型
  • 歷史和預測數據
  • 分析:依產品類型
  • 吸入一氧化氮輸送系統
  • 一氧化氮感測器和監視器

第 6 章:全球醫用吸入一氧化氮市場分析:依給藥途徑

  • 依給藥途徑概述
  • 歷史和預測數據
  • 依給藥途徑分析
  • 吸入一氧化氮氣體
  • 吸入一氧化氮與氧氣混合物

第 7 章:全球醫用吸入一氧化氮市場分析:按應用分類

  • 概述:按應用
  • 歷史和預測數據
  • 分析:按應用
  • 心血管疾病
  • 呼吸系統疾病

第 8 章:全球醫用吸入一氧化氮市場分析:按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫院
  • 診所

第 9 章:全球醫用吸入一氧化氮市場分析:按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第10章:醫用吸入一氧化氮公司的競爭格局

  • 醫用吸入一氧化氮市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章:公司簡介

  • 公司股份分析
  • 市場集中度
  • Bellerophon Therapeutics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Praxair Technology Inc. (Linde plc)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Mallinckrodt Pharmaceuticals
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GE Healthcare
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Mitsubishi Tanabe Pharma Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Vero Biotech LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Messer Group
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Air Liquide
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Nu-Med Plus
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Beyond Air Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • 其他
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中,財務詳細資訊和近期發展視情況而定,或者如果是私人公司,則可能不包括在內

Product Code: VMR112112999

The global demand for Medical Inhaled Nitric Oxide Market is presumed to reach the market size of nearly USD 1892.87 MN by 2030 from USD 985.56 MN in 2022 with a CAGR of 8.5% under the study period 2023 - 2030.

Medical inhaled nitric oxide (iNO) is a gas medication used in the treatment of various respiratory conditions, particularly those involving pulmonary hypertension or hypoxemia (low blood oxygen levels). It is delivered through inhalation as a therapeutic intervention to improve oxygenation and manage pulmonary vascular disorders.

MARKET DYNAMICS

The increasing incidence of respiratory disorders, including acute respiratory distress syndrome (ARDS) and pulmonary hypertension, propels the demand for therapies like inhaled nitric oxide (iNO) to manage these conditions and enhance oxygenation. Within neonatal care, iNO plays a critical role in treating persistent pulmonary hypertension in neonates, aligning with the heightened focus on preterm infant health and advancements in neonatal care practices. Advancements in healthcare technology, improved delivery systems, and monitoring tools enhance the safety and efficacy of iNO therapy, augmenting its adoption in clinical settings. The proven clinical effectiveness of iNO in managing pulmonary vascular disorders and improving oxygenation fosters its acceptance among healthcare professionals. Moreover, ongoing research exploring iNO's potential in treating additional respiratory conditions, alongside regulatory support and increased healthcare spending, collectively drive market expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of medical inhaled nitric oxide. The growth and trends of medical inhaled nitric oxide industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the medical inhaled nitric oxide market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Inhaled Nitric Oxide Delivery Systems
  • Nitric Oxide Sensors And Monitors

By Route Of Administration

  • Inhaled Nitric Oxide Gas
  • Inhaled Nitric Oxide With Oxygen Mixtures

By Application

  • Cardiovascular Disorders
  • Respiratory Disorders

By End User

  • Hospitals
  • Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Inhaled Nitric Oxide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Inhaled Nitric Oxide market include Bellerophon Therapeutics, Praxair Technology Inc. (Linde plc), Mallinckrodt Pharmaceuticals, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Vero Biotech LLC, Messer Group, Air Liquide, Nu-Med Plus, Beyond Air Inc., and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MEDICAL INHALED NITRIC OXIDE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1 Overview by Product Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product Type
  • 5.4 Inhaled Nitric Oxide Delivery Systems Historic and Forecast Sales by Regions
  • 5.5 Nitric Oxide Sensors and Monitors Historic and Forecast Sales by Regions

6 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1 Overview by Route of Administration
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Route of Administration
  • 6.4 Inhaled Nitric Oxide Gas Historic and Forecast Sales by Regions
  • 6.5 Inhaled Nitric Oxide with Oxygen Mixtures Historic and Forecast Sales by Regions

7 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Cardiovascular Disorders Historic and Forecast Sales by Regions
  • 7.5 Respiratory Disorders Historic and Forecast Sales by Regions

8 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Clinics Historic and Forecast Sales by Regions

9 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE MEDICAL INHALED NITRIC OXIDE COMPANIES

  • 10.1. Medical Inhaled Nitric Oxide Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF MEDICAL INHALED NITRIC OXIDE INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Bellerophon Therapeutics
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Praxair Technology Inc. (Linde plc)
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Mallinckrodt Pharmaceuticals
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. GE Healthcare
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Mitsubishi Tanabe Pharma Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Vero Biotech LLC
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Messer Group
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Air Liquide
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Nu-Med Plus
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Beyond Air Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Others
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Inhaled Nitric Oxide Delivery Systems Market Sales by Geography (USD MN)
  • Nitric Oxide Sensors and Monitors Market Sales by Geography (USD MN)
  • Analysis Market by Route of Administration (USD MN)
  • Inhaled Nitric Oxide Gas Market Sales by Geography (USD MN)
  • Inhaled Nitric Oxide with Oxygen Mixtures Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Medical Inhaled Nitric Oxide Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Medical Inhaled Nitric Oxide Report
  • Market Research Process
  • Market Research Methodology
  • Global Medical Inhaled Nitric Oxide Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Inhaled Nitric Oxide Delivery Systems Market Sales by Geography (USD MN)
  • Nitric Oxide Sensors and Monitors Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Inhaled Nitric Oxide Gas Market Sales by Geography (USD MN)
  • Inhaled Nitric Oxide with Oxygen Mixtures Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.